J0889 – Daprodustat, oral, 1 mg, (for esrd on dialysis)
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0889
- Long description
- Daprodustat, oral, 1 mg, (for esrd on dialysis)
- Short description
- Daprodustat oral 1mg esrd
- Pricing indicator
57Other carrier priced- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- October 1, 2023
- Last change
- January 1, 2026 – No change
- Termination date
- December 31, 2025
Frequently asked questions
What is HCPCS code J0889?
J0889 is a HCPCS Level II code for daprodustat, oral, 1 mg, (for esrd on dialysis). It was discontinued on December 31, 2025.
Does Medicare cover J0889?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0881 – Injection, darbepoetin alfa, 1 microgram (non-esrd use)
- J0882 – Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
- J0883 – Injection, argatroban, 1 mg (for non-esrd use)
- J0884 – Injection, argatroban, 1 mg (for esrd on dialysis)
- J0885 – Injection, epoetin alfa, (for non-esrd use), 1000 units
- J0886 – Injection, epoetin alfa, 1000 units (for esrd on dialysis)
- J0887 – Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- J0888 – Injection, epoetin beta, 1 microgram, (for non esrd use)
- J0890 – Injection, peginesatide, 0.1 mg (for esrd on dialysis)
- J0891 – Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0892 – Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0893 – Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
- J0894 – Injection, decitabine, 1 mg
- J0895 – Injection, deferoxamine mesylate, 500 mg
- J0896 – Injection, luspatercept-aamt, 0.25 mg
- J0897 – Injection, denosumab, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.